Swansaw Pharmaceuticals Private Limited
About Swansaw Pharmaceuticals Private Limited
Data last updated:
Swansaw Pharmaceuticals Private Limited is a private limited company based in Visakhapatnam, Andhra Pradesh, India. It was incorporated on 09 June 2023.
The company is registered with the Registrar of Companies (ROC), Vijayawada, under CIN U46497AP2023PTC111413. Its GSTIN is 37ABLCS0285Q1ZI (Andhra Pradesh).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹4 Lakh. It is led by directors Swathi Penki and Poliraju Thattikala.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Visakhapatnam, Andhra Pradesh.
As per the financials filed for FY 2024, the company reported a revenue of ₹4.29 Lakh. For the same year it recorded a net loss of ₹27,264 (net margin -6.3%) and EBITDA of -₹27,264 (EBITDA margin -6.3%).
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered Address27 – 19 – /80 Block B, Fno.408 Srivarshini Homes, Visakhapatnam, Andhra Pradesh, India – 530047
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Swansaw Pharmaceuticals Private Limited
The main business activity of Swansaw Pharmaceuticals is wholesale and retail trade; repair of motor vehicles and motorcycles. In detail, this covers wholesale trade, except of motor vehicles and motorcycles.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Wholesale and retail trade; repair of motor vehicles and motorcycles | 46 | Wholesale trade, except of motor vehicles and motorcycles | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Swansaw Pharmaceuticals Private Limited FY 2025 filings available
Swansaw Pharmaceuticals Private Limited reported revenue of ₹4.29 Lakh for FY 2024.
Financial Statement Summary of Swansaw Pharmaceuticals Private Limited
| Metrics | FY 2023-24 |
|---|---|
| Profit and Loss Statement | |
| Revenue from Operations | •••• |
| Other Income | •••• |
| Total Revenue | •••• |
| Cost of Materials Consumed | •••• |
| Employee Benefit Expense | •••• |
| Finance Costs | •••• |
| Depreciation and Amortisation | •••• |
| Other Expenses | •••• |
| Total Expenses | •••• |
| EBITDA | -₹27,264 |
| Profit Before Tax | •••• |
| Tax Expense | •••• |
| Net Profit (PAT) | -₹27,264 |
| Balance Sheet | |
| Share Capital | •••• |
| Reserves and Surplus | •••• |
| Net Worth (Total Equity) | •••• |
| Long-term Borrowings | •••• |
| Short-term Borrowings | •••• |
| Trade Payables | •••• |
| Total Liabilities | •••• |
| Fixed Assets | •••• |
| Investments | •••• |
| Inventories | •••• |
| Trade Receivables | •••• |
| Cash and Bank Balance | •••• |
| Total Assets | •••• |
Financial Ratios of Swansaw Pharmaceuticals Private Limited
| Metrics | FY 2023-24 |
|---|---|
| Profitability | |
| EBITDA Margin | -6.3% |
| Net Profit Margin | -6.3% |
| Return on Equity (ROE) | •••• |
| Return on Capital Employed (ROCE) | •••• |
| Return on Assets (ROA) | •••• |
| Liquidity and Debt | |
| Current Ratio | •••• |
| Quick Ratio | •••• |
| Debt-to-Equity Ratio | •••• |
| Interest Coverage Ratio | •••• |
| Efficiency and Growth | |
| Asset Turnover | •••• |
| Receivable Days | •••• |
| Payable Days | •••• |
| Inventory Days | •••• |
| Revenue Growth | •••• |
| Net Profit Growth | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Swansaw Pharmaceuticals are in the company report.
Financial statements from FY 2024
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Swansaw Pharmaceuticals Private Limited
Swansaw Pharmaceuticals has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Swathi Penki | Director | 09 Jun 2023 | 3 Years 4 Months | Current |
| Poliraju Thattikala | Director | 09 Jun 2023 | 3 Years 4 Months | Current |
Peer Comparison of Swansaw Pharmaceuticals Private Limited
Swansaw Pharmaceuticals Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Vermas Life Line Biotech Private Limited | ₹4.32 Lakh (FY 2016) | •••• | •••• | 133.0% | •••• | Patna, Bihar, India |
| Medidex Healthcare Private Limited | ₹4.32 Lakh (FY 2024) | •••• | •••• | 98.0% | •••• | Bhopal, Madhya Pradesh, India |
| Byblis Pharmaceuticals Private Limited | ₹4.31 Lakh (FY 2024) | •••• | •••• | 19.0% | •••• | New Delhi, Delhi, India |
| Midstar Pharmaceuticals Private Limited | ₹4.3 Lakh (FY 2025) | •••• | •••• | -59.0% | •••• | Thane, Maharashtra, India |
| Celestis Pharmaceuticals Private Limited | ₹4.3 Lakh (FY 2024) | •••• | •••• | -31.0% | •••• | Ahmedabad, Gujarat, India |
| Swansaw Pharmaceuticals Private Limited this company | ₹4.29 Lakh (FY 2024) | •••• | •••• | •••• | Visakhapatnam, Andhra Pradesh, India | |
| Guyer Pharmaceuticals Private Limited | ₹4.29 Lakh (FY 2019) | •••• | •••• | -9.0% | •••• | Daltonganj, Jharkhand, India |
| Brizwell Pharmaceuticals Private Limited | ₹4.29 Lakh (FY 2024) | •••• | •••• | •••• | Secunderabad, Telangana, India | |
| True Pill Pharmaceuticals Private Limited | ₹4.28 Lakh (FY 2024) | •••• | •••• | 132.0% | •••• | Bulandshahar, Uttar Pradesh, India |
| Medwock Pharmaceuticals Private Limited | ₹4.28 Lakh (FY 2020) | •••• | •••• | •••• | New Delhi, Delhi, India | |
| Gargi Pharma Private Limited | ₹4.27 Lakh (FY 2022) | •••• | •••• | -51.0% | •••• | Nashik, Maharashtra, India |
Peers are the five companies nearest above and the five nearest below Swansaw Pharmaceuticals by revenue in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Charges & Borrowings of Swansaw Pharmaceuticals Private Limited
Swansaw Pharmaceuticals Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Swansaw Pharmaceuticals Private Limited
Employment history and EPFO contributions of people linked to Swansaw Pharmaceuticals.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Swansaw Pharmaceuticals Private Limited
Swansaw Pharmaceuticals Private Limited has 2 board changes on record since 2023: 2 appointments. The latest: Poliraju Thattikala was appointed as Director on 09 Jun 2023.
Credit Ratings, Litigation & Regulatory Alerts for Swansaw Pharmaceuticals Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Swansaw Pharmaceuticals Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Swansaw Pharmaceuticals Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Swansaw Pharmaceuticals Private Limited
Swansaw Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 37ABLCS0285Q1ZI | Andhra Pradesh | Active | 05 Sep 2023 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Swansaw Pharmaceuticals Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Swansaw Pharmaceuticals Private Limited
Swansaw Pharmaceuticals is an active private limited company based in Visakhapatnam, Andhra Pradesh, India. It was incorporated on 09 June 2023 (3+ years old) and is registered under CIN U46497AP2023PTC111413.
Swansaw Pharmaceuticals reported revenue of ₹4.29 Lakh for FY 2024.
Swansaw Pharmaceuticals has 2 current directors:
- Swathi Penki - Director
- Poliraju Thattikala - Director
Swansaw Pharmaceuticals reported a net loss of ₹27,264 (net margin -6.3%) and EBITDA of -₹27,264 (EBITDA margin -6.3%) for FY 2024, as per its filed financial statements.
The GSTIN of Swansaw Pharmaceuticals is 37ABLCS0285Q1ZI, registered in Andhra Pradesh.
The CIN (Corporate Identification Number) of Swansaw Pharmaceuticals is U46497AP2023PTC111413. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Swansaw Pharmaceuticals was incorporated on 09 June 2023, making it 3+ years old. It is registered with the Registrar of Companies, Vijayawada.
The peers of Swansaw Pharmaceuticals by revenue are Vermas Life Line Biotech Private Limited, Medidex Healthcare Private Limited, Byblis Pharmaceuticals Private Limited, Midstar Pharmaceuticals Private Limited, Celestis Pharmaceuticals Private Limited and 5 more, all in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals).
Poliraju Thattikala was appointed as Director on 09 Jun 2023. Swathi Penki was appointed as Director on 09 Jun 2023.
The registered office of Swansaw Pharmaceuticals is at 27 – 19 – 80 Block B, Fno.408 Srivarshini Homes, Visakhapatnam, Andhra Pradesh, India – 530047.
Swansaw Pharmaceuticals has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹4 Lakh.